Sally C. Medley

Array ( [id] => 3106496 [patent_doc_number] => 05407820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-18 [patent_title] => 'Calcium channel .alpha.-2 subunit DNAs and cells expressing them' [patent_app_type] => 1 [patent_app_number] => 7/914231 [patent_app_country] => US [patent_app_date] => 1992-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10098 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/407/05407820.pdf [firstpage_image] =>[orig_patent_app_number] => 914231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3023605 [patent_doc_number] => 05316763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-31 [patent_title] => 'Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity' [patent_app_type] => 1 [patent_app_number] => 7/910835 [patent_app_country] => US [patent_app_date] => 1992-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 7913 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/316/05316763.pdf [firstpage_image] =>[orig_patent_app_number] => 910835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3003263 [patent_doc_number] => 05330754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-19 [patent_title] => 'Membrane-associated immunogens of mycobacteria' [patent_app_type] => 1 [patent_app_number] => 7/906395 [patent_app_country] => US [patent_app_date] => 1992-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 9245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/330/05330754.pdf [firstpage_image] =>[orig_patent_app_number] => 906395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824842 [patent_doc_number] => 05759803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA' [patent_app_type] => 1 [patent_app_number] => 7/882711 [patent_app_country] => US [patent_app_date] => 1992-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6395 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759803.pdf [firstpage_image] =>[orig_patent_app_number] => 882711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3441707 [patent_doc_number] => 05419899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-30 [patent_title] => 'Purified, reduced recombinant interleukin-2 compositions' [patent_app_type] => 1 [patent_app_number] => 7/879753 [patent_app_country] => US [patent_app_date] => 1992-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5793 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/419/05419899.pdf [firstpage_image] =>[orig_patent_app_number] => 879753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101754 [patent_doc_number] => 05447861 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'Continuous mammalian cell lines having monocyte/macrophage characteristics and their establishment in vitro' [patent_app_type] => 1 [patent_app_number] => 7/878253 [patent_app_country] => US [patent_app_date] => 1992-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8482 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447861.pdf [firstpage_image] =>[orig_patent_app_number] => 878253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580921 [patent_doc_number] => 05580775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'High affinity, brain-specific nucleic acids encoding a L-proline transporter, and vectors, and host cells comprising the same' [patent_app_type] => 1 [patent_app_number] => 7/879617 [patent_app_country] => US [patent_app_date] => 1992-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 12781 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580775.pdf [firstpage_image] =>[orig_patent_app_number] => 879617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3984597 [patent_doc_number] => 05910304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Low-dose oral administration of interferons' [patent_app_type] => 1 [patent_app_number] => 7/875630 [patent_app_country] => US [patent_app_date] => 1992-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7680 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910304.pdf [firstpage_image] =>[orig_patent_app_number] => 875630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3410793 [patent_doc_number] => 05461029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Method of treating herpes viral infections using HBNF and MK proteins' [patent_app_type] => 1 [patent_app_number] => 7/874848 [patent_app_country] => US [patent_app_date] => 1992-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6819 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/461/05461029.pdf [firstpage_image] =>[orig_patent_app_number] => 874848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3026724 [patent_doc_number] => 05316920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-31 [patent_title] => 'Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily' [patent_app_type] => 1 [patent_app_number] => 7/870029 [patent_app_country] => US [patent_app_date] => 1992-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 7547 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/316/05316920.pdf [firstpage_image] =>[orig_patent_app_number] => 870029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3600790 [patent_doc_number] => 05578466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system' [patent_app_type] => 1 [patent_app_number] => 7/872673 [patent_app_country] => US [patent_app_date] => 1992-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24571 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578466.pdf [firstpage_image] =>[orig_patent_app_number] => 872673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3537503 [patent_doc_number] => 05494806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'DNA and vectors encoding the parathyroid hormone receptor, transformed cells, and recombinant production of PTHR proteins and peptides' [patent_app_type] => 1 [patent_app_number] => 7/864475 [patent_app_country] => US [patent_app_date] => 1992-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 18353 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494806.pdf [firstpage_image] =>[orig_patent_app_number] => 864475 [rel_patent_id] =>[rel_patent_doc_number] =>)